Publications by authors named "Yosef Samih"
This study investigates breast cancer survival rates between 2000 and 2022 in northern Israel, focusing on ethnicity, socioeconomic status, age at diagnosis, and the Charlson Comorbidity Index. Analyzing data from Clalit Health Services, we studied 8,431 breast cancer patients (6,395 Jewish, 2,036 Arab). We compared five- and ten-year survival rates across different demographics.
View Article and Find Full Text PDFArticle Synopsis
- A real-world study assessed the benefit of adjuvant chemotherapy (CT) in early-stage breast cancer patients with a Recurrence Score (RS) of 26-30, using data from 534 patients.
- The study found that, despite imbalances in risk factors between CT-treated and untreated groups, overall survival (OS) and distant recurrence-free survival (DRFS) were similar for N0 patients regardless of treatment.
- In N1mi/N1 patients, while OS and DRFS were comparable between treatment groups, a notable difference in breast cancer-specific mortality (BCSM) was observed, indicating a potential benefit of CT for those patients.